| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,286 |
2,332 |
$232K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
10,102 |
2,940 |
$90K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,163 |
469 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,458 |
838 |
$27K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
567 |
281 |
$13K |
| 0240U |
|
87 |
74 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
147 |
39 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
74 |
74 |
$3K |
| 87428 |
|
21 |
16 |
$1K |